Importantly, the brain GLUT4 content, which was reduced by DM, has been recovered by metformin, with an even higher response with the association of the two drugs [81]; thus, the authors propose that the combination metformin/donepezil should be considered for managing DM-associated dementia [81]. This evidence concerns the gene SLC2A4 and diabetes mellitus.